Momelotinib During and After HCT in Myelofibrosis

Abroad (travel likely)RecruitingPHASE1

Conditions

Myelofibrosis · Hematopoietic Cell Transplantation (HCT)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Massachusetts General Hospital, Boston, Massachusetts, United States
Contact: Study coordinator (Gabriela Hobbs, MD) · ghobbs@mgb.org · (617) 726-8748
Contact: Principal Investigator (Gabriela Hobbs, MD)

Study leads

Gabriela Hobbs, MD
Principal Investigator
Massachusetts General Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Study of Momelotinib in Combination With Luspatercept in Participants With Transfusion Dependent Myelofibrosis

Primary Myelofibrosis · Myelofibrosis; Primary Myelofibrosis; Post-polycythemia Vera Myelofibrosis; Post-essential Thrombocythemia Myelofibrosis

Abroad (travel likely)RecruitingPHASE2

Ann Arbor, United States · New York, United States

A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant

Accelerated Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive · Acute Lymphoblastic Leukemia · Acute Myeloid Leukemia

Abroad (travel likely)RecruitingPHASE1

Duarte, United States · Atlanta, United States

Hyperbaric Oxygen Therapy and Allogeneic Peripheral Blood Stem Cell (PBSC) Transplant

Acute Myeloid Leukemia · Myelodysplastic Syndromes · Chronic Myelomonocytic Leukemia

Abroad (travel likely)RecruitingEARLY_PHASE1

Rochester, United States

Therapeutic RSK1 Targeting in Myelofibrosis

Myelofibrosis

Abroad (travel likely)RecruitingPHASE1

St Louis, United States